Unlocking the potential of epigenetics for early cancer detection and personalized health solutions.

Our mission is to transform healthcare by providing solutions for making critical health decisions and detecting cancer earlier than ever thought possible.

Receive Epigenetics Updates

Stay updated on advancements in epigenetics and personalized health with our newsletter.

The power of epigenetics

The key to saving lives hinges on the meticulous ability to detect and diagnose diseases at their earliest stages. Enter our revolutionary approach: harnessing epigenetics for early cancer detection.

The synergy between our detection methods, products, and patient choices underscores a holistic approach to proactive healthcare management, promoting longevity and global health.

Scientific approach

Scientific approach

Our method unveils unique epigenetic traits of cancer cells. By focusing on the epigenetic profile of DNA, we empower individuals with knowledge & tools for proactive health management.

Our Lab

Our Lab

Our advanced laboratory seamlessly blends science and precision for cutting-edge DNA analysis, specializing in epigenetics and early cancer detection.

Trials

Trials

Our clinical trials provide invaluable insights into the applicability and impact of our work in early cancer diagnosis on a global scale.

epiAge App®

epiAge App®

Get the full experience of our EpiAging service, including test result checking, lifestyle questionnaires, and personalized health advice.

Our Products

Our products target early disease detection including liver cancer, breast cancer,
cervical cancer, and monitor exposure to tobacco smoke.
  • Personal Health

    MetaGen Mutations Multi-Test

    MGMT gene testing serves as a crucial tool for physicians and surgeons in tailoring precise cancer treatment plans. This genetic test delves into the intricacies of the MGMT gene, a key player in the body's response to chemotherapy.  By understanding the genetic characteristics related to this gene, physicians gain valuable insights into the patient's likelihood of responding to chemotherapy and can customize treatment strategies accordingly.  MGMT gene testing stands at the forefront of personalized medicine, enabling healthcare professionals to make informed decisions about chemotherapy prescriptions based on the patient's unique genetic profile, ultimately optimizing the effectiveness of cancer treatment.

    $599.00
    Rated 0 out of 5

    $599.00Add to cart

  • Personal Health

    epiAge

    Did you know that it’s possible to detect your body’s true age?  It is through this easy to take detection test. Stop counting your age by birthdays and start determining your age based on your DNA, lifestyle choices, and hidden genetic stories. 

    $199.00
    Rated 0 out of 5

    $199.00Add to cart

  • Personal Health

    epiPsych

    HKG epiTherapeutics is proud to introduce epiPsych, a pioneering saliva-based epigenetic test designed to uncover the genetic underpinnings of psychiatric conditions. This innovative approach offers a non-invasive pathway to gaining profound insights into the epigenetic factors influencing mental health.

    MTL Epitherapeutics is proud to introduce epiPsych to the Canadian market, a pioneering saliva-based epigenetic test designed to uncover the genetic underpinnings of psychiatric conditions. This innovative approach offers Canadians a non-invasive pathway to gaining profound insights into the epigenetic factors influencing mental health.

    $499.00
    Rated 0 out of 5

    $499.00Add to cart

  • Cancer Detection

    epiPancancer

    Thanks to the development of our epiPancancer, we can detect up to 33 different types of cancer. Current biomarkers lack sensitivity and specificity to detect cancer early. Available biomarkers and diagnostic methods are invasive and cannot be used for follow-up of a healthy population. Our scientists conducted multiple cancer blood tests to investigate DNA methylation results from normal tissues, blood, and cancer from thousands of people and used proprietary methods to discover unique methylation profiles that are categorically different between each tissue type.  Our new Binary Categorical Differentiation (BCD) method identifies stark differences between cancer cells and normal cells.

    Rated 0 out of 5
  • Cancer Detection

    epiCervix

    We are advancing our capabilities by incorporating human papillomavirus (HPV) testing in cervical biopsies. While Pap smear has traditionally focused on identifying abnormal cells in the cervix, our ongoing research extends its utility to include the detection of HPV, offering a more comprehensive assessment of cervical health.

    $899.00
    Rated 0 out of 5

    $899.00Add to cart

  • Cancer Detection

    epiLiver

    This is a liquid biopsy for early detection of liver cancer that detects conversion of patients with chronic hepatitis or healthy controls to early-stage liver cancer HCC. This is a next-generation sequencing assay that is fully optimized and clinically tested. Targets were clinically validated in studies in Yuan Hospital in Beijing and published in Clinical Epigenetics 2018. epiLiver has PCT world patent protection in the U.S., Europe, Canada, Indonesia, India, and Japan. 

    $699.00
    Rated 0 out of 5

    $699.00Add to cart

Resources

Whether you’re seeking updates on the latest advancements, exploring our recent media hits, or delving into the science behind health and longevity solutions, you’ll find a wealth of valuable information to enrich your knowledge of our mission.

Social Media

Scroll to Top